Laparoscopic first step approach in the two stage hepatectomy
Giovanni Battista Levi Sandri1, Lidia Colace1, Giovanni Vennarecci1
1Division of General Surgery and Liver Transplantation, San Camillo Hospital, Rome, Lazio, Italy.
Hepatobiliary Surgery and Nutrition
|November 26, 2015
Summary
Laparoscopic approach for the first step of two-stage hepatectomy is feasible for colorectal liver metastases. This minimally invasive technique shows low morbidity and mortality, enabling liver resection in patients with limited future liver remnant (FLR).
Area of Science:
- Hepatobiliary Surgery
- Minimally Invasive Surgery
- Surgical Oncology
Background:
- Resection is the primary treatment for colorectal liver metastases, but only 20-30% of patients are eligible.
- Limited future liver remnant (FLR) often precludes single-stage resection.
- Two-stage hepatectomy is an alternative for extensive bilobar disease.
Purpose of the Study:
- To assess the feasibility, morbidity, and mortality of a laparoscopic approach for the first stage of two-stage hepatectomy.
- To evaluate this technique in patients with colorectal liver metastases and insufficient FLR.
Main Methods:
- Retrospective analysis of 73 patients undergoing two-stage hepatectomy from 2004 to March 2014.
- Four patients underwent a totally laparoscopic first step: wedge liver resection and portal vein ligation (PVL).
- Procedures included segment II-III or segment III wedge resections with laparoscopic PVL (LPVL).
Main Results:
- The laparoscopic first stage involved wedge resection and LPVL with a mean operative time of 189 minutes.
- Mean blood loss was minimal (22 cc), with no transfusions required.
- The procedure was feasible in patients with bilobar liver metastases.
Conclusions:
- The first stage of two-stage hepatectomy, including hepatic resection and PVL, is feasible using a laparoscopic approach.
- This minimally invasive strategy is suitable for patients with bilobar liver metastases requiring staged resection.
- The laparoscopic approach demonstrates low blood loss and avoids transfusions, suggesting favorable early outcomes.


